Cargando…
Retraction: Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552831/ https://www.ncbi.nlm.nih.gov/pubmed/34558547 http://dx.doi.org/10.4103/1673-5374.295353 |
Ejemplares similares
-
Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
por: Ghali, George Zaki, et al.
Publicado: (2020) -
Retraction: Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection
Publicado: (2022) -
Fatal anaphylaxis Due to Nafamostat Mesylate During Hemodialysis
por: Kim, Joo-Hee, et al.
Publicado: (2021) -
Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis
por: Shioya, Nobuki, et al.
Publicado: (2022) -
Retraction: Ki20227 aggravates apoptosis, inflammatory response, and oxidative stress after focal cerebral ischemia injury
Publicado: (2022)